United States · 
Who invested in Sparrow Pharmaceuticals?
Sparrow Pharmaceuticals's investors include OrbiMed, RA Capital Management and Forbion Capital Partners.
United States · Series B startup
Who invested in Sparrow Pharmaceuticals
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$95Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $95MSept 2025
- Investors
- 3
The rounds
- Sept 2025Series B$95M
Source recordedSEC filing: $62M sold, first sale Jun 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Sparrow Pharmaceuticals
How much has Sparrow Pharmaceuticals raised?
Sparrow Pharmaceuticals has raised $95M across 1 round since 2025.
When did Sparrow Pharmaceuticals last raise?
Sparrow Pharmaceuticals's most recent round was a Series B of $95M in Sept 2025.
What was Sparrow Pharmaceuticals's biggest round?
Its most recent round, $95M in Sept 2025, is also its largest on record.
Who backed Sparrow Pharmaceuticals first?
Sparrow Pharmaceuticals's first round on record, in Sept 2025, was backed by OrbiMed, RA Capital Management and Forbion Capital Partners.
What stage is Sparrow Pharmaceuticals at?
Sparrow Pharmaceuticals's latest named round is a Series B, in Sept 2025.
Where is Sparrow Pharmaceuticals based?
Sparrow Pharmaceuticals is based in the United States.
Companies like Sparrow Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.